242 related articles for article (PubMed ID: 33319385)
21. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
22. Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: a prospective study.
Nam IC; Park JO; Joo YH; Cho KJ; Kim MS
Head Neck; 2013 Jan; 35(1):40-5. PubMed ID: 22266805
[TBL] [Abstract][Full Text] [Related]
23. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
24. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma.
Ito Y; Hirokawa M; Jikuzono T; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2007 Jun; 31(6):1194-201. PubMed ID: 17431714
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma.
Heaton CM; Chang JL; Orloff LA
Thyroid; 2016 Mar; 26(3):434-40. PubMed ID: 26825749
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Level VII Nodal Dissection as a Prognostic Factor in Papillary Thyroid Carcinoma: a Pilot Study of 27 Patients.
Fayek IS
Asian Pac J Cancer Prev; 2015; 16(10):4211-4. PubMed ID: 26028074
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
28. Correlation of minimal extrathyroidal extension with pathologic features of lymph node metastasis in patients with papillary thyroid carcinoma.
Lee HS; Park C; Kim SW; Park T; Chun BK; Hong JC; Lee KD
J Surg Oncol; 2015 Nov; 112(6):592-6. PubMed ID: 26421594
[TBL] [Abstract][Full Text] [Related]
29. Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.
Wang LY; Palmer FL; Nixon IJ; Thomas D; Shah JP; Patel SG; Tuttle RM; Shaha AR; Ganly I
Thyroid; 2014 Dec; 24(12):1790-5. PubMed ID: 25268855
[TBL] [Abstract][Full Text] [Related]
30. Impact of microscopic extra-nodal extension (ENE) on locoregional recurrence following curative surgery for papillary thyroid carcinoma.
Lang BH; Shek TW; Wan KY
J Surg Oncol; 2016 Apr; 113(5):526-31. PubMed ID: 26792294
[TBL] [Abstract][Full Text] [Related]
31. The prognostic factors for clinical N1b patients in thyroid papillary carcinoma.
Yuksel UM; Turanli S; Acar Y; Berberoglu U
J Cancer Res Ther; 2019; 15(3):681-685. PubMed ID: 31169240
[TBL] [Abstract][Full Text] [Related]
32. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
Lee CH; Lee SW; Son SH; Hong CM; Jeong JH; Jeong SY; Ahn BC; Lee J
Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
[No Abstract] [Full Text] [Related]
33. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
[TBL] [Abstract][Full Text] [Related]
34. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
Ryu YJ; Cho JS; Yoon JH; Park MH
World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
[TBL] [Abstract][Full Text] [Related]
36. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
37. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma.
Wu Y; Li J; Wu X; Dai L
Curr Pharm Des; 2018; 24(5):559-563. PubMed ID: 28990528
[TBL] [Abstract][Full Text] [Related]
38. Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.
Jeon MJ; Kim YN; Sung TY; Hong SJ; Cho YY; Kim TY; Shong YK; Kim WB; Kim SW; Chung JH; Kim TH; Kim WG
Thyroid; 2018 Feb; 28(2):193-200. PubMed ID: 29179646
[TBL] [Abstract][Full Text] [Related]
39. Medullary thyroid cancer: What is the optimal management of the lateral neck in a node negative patient at index operation?
Szabo Yamashita T; Rogers RT; Foster TR; Lyden ML; Morris JC; Thompson GB; McKenzie T; Dy BM
Surgery; 2022 Jan; 171(1):177-181. PubMed ID: 34284893
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic characteristics and pattern of central lymph node metastasis in papillary thyroid cancer located in the isthmus.
Lee YC; Na SY; Chung H; Kim SI; Eun YG
Laryngoscope; 2016 Oct; 126(10):2419-21. PubMed ID: 27098428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
